共查询到20条相似文献,搜索用时 140 毫秒
1.
目的观察12/15脂氧合酶抑制剂CDC对大鼠胰岛B细胞中环加氧酶2(COX-2)的表达及前列腺素E2(PGE2)生成的影响,并初步探讨其机制。方法体外培养大鼠胰岛β细胞系INS-1细胞,加入细胞因子IL-1β诱导COX-2蛋白的表达,然后采用Western印迹的方法观察12/15脂氧合酶抑制剂cin-naminyl-3,4-dihydroxy-α-cyanocinnamate(CDC)对COX-2蛋白表达的影响;借助萤光素酶报告基因技术检测CDC对COX-2启动子转录活性的影响,最后用放射免疫法了解CDC对胰岛B细胞中PGE2生成的抑制作用。结果细胞因子IL-1p能够在大鼠胰岛β细胞系INS-1中诱导COX-2基因的表达,而12/15脂氧合酶抑制剂CDC能够呈剂量依赖抑制IL-1p所诱导的COX-2蛋白的表达。结论12/15脂氧合酶抑制剂能够明显抑制炎性因子IL-1β所诱导的胰岛β细胞中COX-2的表达和炎性介质PGE2的生成。 相似文献
2.
环氧合酶-2 (cyclooxygenase-2,COX-2)是催化花生四烯酸转化为前列腺素的限速酶,广泛参与脑创伤、缺血诱导的神经元损伤、炎症反应及神经变性性疾病等.COX-2在神经病理学中的作用与神经元的突触变化有关.增强或抑制COX-2表达可增强或抑制兴奋性谷氨酸能神经元的神经传递和长时程增强 (LTP),这些效应由COX-2的主要产物前列腺素E2(PGE2)及其受体亚型EP2所介导.因此,阐明COX-2在突触信号中的作用机制将有助于设计新的药物来预防、治疗及减轻神经源性炎症相关的神经紊乱性疾病. 相似文献
3.
环氧合酶-2(Cyclooxygenase-2,COX-2)是前列腺素合成过程中一重要的限速酶,COX-2的过度表达及其前列腺素产物与多种肿瘤的发生、发展关系密切,COX-2抑制剂通过抑制肿瘤细胞增殖,诱导肿瘤细胞凋亡,阻断致癌物的代谢,减弱肿瘤介导的免疫抑制,调节抑制血管生成,抑制肿瘤细胞侵袭,环氧合酶非依赖抑癌途径,对原癌基因及抑癌基因的影响等途径影响肿瘤的发生发展,这方面的研究为针对COX-2的抗肿瘤策略打开新的视野,提供新的线索。 相似文献
4.
环氧合酶-2(Cyclooxygenase-2,COX-2)是前列腺素合成过程中一重要的限速酶,COX-2的过度表达及其前列腺素产物与多种肿瘤的发生、发展关系密切,COX-2抑制剂通过抑制肿瘤细胞增殖,诱导肿瘤细胞凋亡,阻断致癌物的代谢,减弱肿瘤介导的免疫抑制,调节抑制血管生成,抑制肿瘤细胞侵袭,环氧合酶非依赖抑癌途径,对原癌基因及抑癌基因的影响等途径影响肿瘤的发生发展,这方面的研究为针对COX-2的抗肿瘤策略打开新的视野,提供新的线索。 相似文献
5.
摘要:缓激肽B1受体(bradykinin 1 receptors,B1Rs)是与Gq蛋白相偶联的受体。正常状态下,B1R除了在神经系统中(如脊髓背角浅层和感觉神经节)有少数表达外,其他机体组织中几乎不存在。在炎症或者神经受损的情况下,脊髓背角浅层和感觉神经节B1R表达量大大上升,参与炎性疼痛和神经病理性疼痛的产生和维持。近年来的研究表明,B1R在糖尿病性神经病理疼痛的发病中起着重要的作用。阻断B1R能有效抑制糖尿病诱发的热痛觉过敏和冷觉及触觉超敏。此外,B1R和癌症痛的发生也有密切关系,所以,对B1R的研究可能会为治疗这些临床顽症提供新的靶点。关键词:缓激肽B1受体;炎性痛;神经病理性痛中图分类号:Q189;Q42;R338文献标志码:A 相似文献
6.
宋施委 《现代生物医学进展》2006,6(10):108-110
环氧合酶(cyclooxygenase,COX)又名前列腺素内过氧化物合成酶,是前列腺素类似物合成的限速酶。COX-2是其诱导型酶。胶质瘤中COX-2的高表达被认为与肿瘤的侵袭性、预后相关。COX-2在胶质瘤的发生发展过程中发挥重要作用。选择性COX-2抑制剂通过直接和间接的作用机制而成为放射增敏剂。它们通过直接作用肿瘤细胞增强放射反应性,同时间接通过前列腺素影响肿瘤的血管形成抑制肿瘤生长。在体内和体外的研究表明选择性COX-2抑制剂可以增强胶质瘤对放射的反应性.降低恶性胶质瘤患者术后放射的必需照射剂量。而且在提高肿瘤放射敏感性的同时不增加对正常组织的放射损伤,甚至对正常组织有放射保护作用。因此,放疗联合选择性COX-2抑制剂可能成为胶质瘤治疗的新的有效途径。 相似文献
7.
目的:研究缓激肽B2受体(BDKRB2)基因多态性对骨关节炎的易感性和严重性的影响.方法:在325名原发性膝关节骨关节炎患者及318名健康志愿者中,针对缓激肽B2受体基因多态性-58T/C和+9/-9bp,分别进行基因型测定.结果:+9/-9bp基因多态性的基因型分布和等位基因频率,在骨关节炎组与对照组之间存在明显差异.回归分析显示-9/-9基因型相对于+9/+9基因型,罹患膝关节骨关节炎的风险明显增高(OR=2.354,P<0.001).同时,+9/-9bp基因多态性与骨关节炎的放射学分型存在相关性,-9bp等位基因可能与骨关节炎的严重程度有关.-58T/C基因多态性与骨关节炎的易感性和严重性无相关性.结论:缓激肽B2受体基因多态性+9/-9bp可能成为检测骨关节炎易感性和严重性的基因标记物. 相似文献
8.
为了探讨雌激素对发育期大鼠海马NMDA受体活性的快速影响,对出生后18d的雄性大鼠进行苯甲酸雌二醇皮下注射,1h后用WesternBlot检测海马NMDA受体NR1和NR2B亚基、雌激素β受体、ERK1/2蛋白的表达,以及NR2B和ERK1/2的磷酸化水平;并通过海马内给予雌激素受体拮抗剂ICI182,780和MEK1/2抑制剂U0126预处理,进一步分析苯甲酸雌二醇影响NR2B和ERK1/2磷酸化的作用机制。结果显示,苯甲酸雌二醇不影响NR1、NR2B、ERβ和ERK1/2的表达,但能快速增强NR2B和ERK1/2的磷酸化水平。雌激素受体拮抗剂ICI182,780和MEK1/2抑制剂U0126均能明显抑制苯甲酸雌二醇诱导的NR2B和ERK1/2磷酸化水平的增加。以上结果提示,雌激素可能通过雌激素受体的非基因组机制激活ERK/MAPK信号转导通路,快速诱导NMDA受体NR2B亚基磷酸化,激活NMDA受体。 相似文献
9.
神经生长因子是神经营养因子家族成员之一,对不同时期神经元的存活、分化、生长及损伤后的修复和再生都有着十分重要的作用。不仅在神经系统中,随着人类的其他正常和肿瘤组织中同样也检测得到了NGF,神经生长因子在各方面的应用也得到了重视并均已得到了证实。NGF功能的发挥离不开与其受体的结合,根据NGF表面糖蛋白与凝集素结合能力的不同,其受体可被分为高亲和力受体酪氨酸激酶A和低亲和力受体p75。Trk A与NGF结合后所介导的信号通路主要有:1MAPK通路;2PLC-γ通路;3PI3K/PKB通路。而p75与NGF结合介导的信号传导通路主要包括:1NF-κB通路;2JNK-p53-Bax凋亡通路;3神经酰胺通路。Trk A一般介导的是正性信号,如促进神经细胞生长、维持神经细胞的存活等;而p75既可促进神经细胞存活,也可诱导神经细胞凋亡,但以后者为主。当Trk A与p75同时表达时,Trk A可抑制p75诱导细胞凋亡,使受损神经细胞大量增殖,所以其生物学总效应是促进神经细胞的生长和存活。 相似文献
10.
目的:探讨缓激肽(BK)B1受体在ACEI类药物卡托普利(captopril)抑制血管紧张素Ⅱ(AngⅡ)诱导的新生大鼠心脏成纤维细胞(CR)增殖中的作用及其可能机制。方法:经差速贴壁法培养新生大鼠CFs,随机给予AngⅡ、captopfil、B2受体阻断剂icatibant和BJ受体阻断剂des-Arg^10,Leu^9-kallidin进行干预。采用四氮唑盐(MTT)比色法测细胞数目,流式细胞仪技术(FCM)检测细胞周期,硝酸还原酶法和放射免疫分析技术分别测定培养CR细胞上清液中NO含量和细胞内cGMP水平。结果:与空白对照组比较,AngⅡ10^-7mol/L孵育细胞48h后可显著升高CRS期细胞百分率和MTT比色法测定的CFs吸光度(A490nm)值(P〈0.01);Captopril 10^-5mol/L可明显降低AngⅡ刺激的CFsS期细胞百分率和A490nm值升高(均P〈0.05),显著促进CFsNO和cGMP生成,该作用可被icatibant(10^-6mol/L)部分阻断,同时阻断B1和B2受体可进一步减弱captopril的作用。结论:Captopril抑制AngⅡ诱导的CFs增殖作用部分是由BK经其B2受体介导的;同时阻断BK B1和B2受体可进一步减弱captopril抗CR增殖效应,B1受体在B2受体阻断情况下可能起部分代偿作用,抑制CFs生长,该作用与NO、cGMP生成有关。 相似文献
11.
12.
Sandie I. Briand Sylvie G. Bernier Gatan Guillemette 《Journal of cellular biochemistry》1996,63(3):292-301
We provided evidence that calcium-calmodulin plays a major role in bradykinin-induced arachidonic acid release by bovine aortic endothelial cells. In cells labeled for 16 hr with 3H-arachidonic acid, ionomycin and Ca2+-mobilizing hormones such as bradykinin, thrombin and platelet activating factor induced arachidonic acid release. However, arachidonic acid release was not induced by agents known to increase cyclic AMP (forskolin, isoproterenol) or cyclic GMP (sodium nitroprusside). Bradykinin induced the release of arachidonic acid in a dose-dependent manner (EC50 = 1.6 ± 0.7 nM). This increase was rapid, reaching a maximal value of fourfold above basal level in 15 min. In a Ca2+-free medium, bradykinin was still able to release arachidonic acid but with a lower efficiency. Quinacrine (300 μM), a blocker of PLA2, completely inhibited bradykinin-induced arachidonic acid release. The B2 bradykinin receptor antagonist HOE-140 completely inhibited bradykinin-induced arachidonic acid release. The B1-selective agonist DesArg9-bradykinin was inactive and the B1-selective antagonist [Leu8]DesArg9-bradykinin had no significant effect on bradykinin-induced arachidonic acid release. The phospholipase C inhibitor U-73122 (100 μM) decreased bradykinin-induced arachidonic acid release. The calmodulin inhibitor W-7 (50 μM) drastically reduced the bradykinin- and ionomycin-induced arachidonic acid release. Also, forskolin decreased bradykinin-induced arachidonic acid release. These results suggest that the activation of PLA2 by bradykinin in BAEC is a direct consequence of phospholipase C activation. Ca2+-calmodulin appears to be the prominent activator of PLA2 in this system. © 1996 Wiley-Liss, Inc. 相似文献
13.
Bradykinin releases acetylcholine from myenteric plexus by a prostaglandin-mediated mechanism 总被引:2,自引:0,他引:2
Release of [3H]acetylcholine (ACh) under the influence of bradykinin was measured from myenteric plexus-longitudinal muscle strips taken from guinea pig small intestine. Bradykinin stimulated the efflux of [3H]ACh in a dose-dependent manner. This stimulation by bradykinin was resistant to the effect of [Des-Arg9-Leu8]-bradykinin but not to indomethacin, indicating that the ACh-releasing action of bradykinin was mediated indirectly by a prostaglandin mechanism. Direct evidence for a stimulation of ACh release by prostaglandin E1 was obtained. Prostaglandin was able to stimulate ACh release in a dose-related fashion. The inhibition of bradykinin-induced ACh release by indomethacin was partly reversed by exogenous prostaglandin E1. These results suggest a neuromodulatory role for bradykinin in the enteric nervous system. 相似文献
14.
Tjwa ET Bradley JM Keenan CM Kroese AB Sharkey KA 《American journal of physiology. Gastrointestinal and liver physiology》2003,285(6):G1268-G1276
Fos expression was used to assess whether the proinflammatory cytokine interleukin-1beta (IL-1beta) activated specific, chemically coded neuronal populations in isolated preparations of guinea pig ileum and colon. Whether the effects of IL-1beta were mediated through a prostaglandin pathway and whether IL-1beta induced the expression of cyclooxygenase (COX)-2 was also examined. Single- and double-labeling immunohistochemistry was used after treatment of isolated tissues with IL-1beta (0.1-10 ng/ml). IL-1beta induced Fos expression in enteric neurons and also in enteric glia in the ileum and colon. For enteric neurons, activation was concentration-dependent and sensitive to indomethacin, in both the myenteric and submucosal plexuses in both regions of the gut. The maximum proportion of activated neurons differed between the ileal (approximately 15%) and colonic (approximately 42%) myenteric and ileal (approximately 60%) and colonic (approximately 75%) submucosal plexuses. The majority of neurons activated in the myenteric plexus of the ileum expressed nitric oxide synthase (NOS) or enkephalin immunoreactivity. In the colon, activated myenteric neurons expressed NOS. In the submucosal plexus of both regions of the gut, the majority of activated neurons were vasoactive intestinal polypeptide (VIP) immunoreactive. After treatment with IL-1beta, COX-2 immunoreactivity was detected in the wall of the gut in both neurons and nonneuronal cells. In conclusion, we have found that the proinflammatory cytokine IL-1beta specifically activates certain neurochemically defined neural pathways and that these changes may lead to disturbances in motility observed in the inflamed bowel. 相似文献
15.
Neurotransmitter release from bradykinin-stimulated PC12 cells. Stimulation of cytosolic calcium and neurotransmitter release. 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《The Biochemical journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
The effect of bradykinin on intracellular free Ca2+ and neurotransmitter secretion was investigated in the rat pheochromocytoma cell line PC12. Bradykinin was shown to induce a rapid, but transient, increase in intracellular free Ca2+ which could be separated into an intracellular Ca2+ release component and an extracellular Ca2+ influx component. The bradykinin-induced stimulation of intracellular free Ca2+ displayed a similar time course, concentration dependencies and extracellular Ca2+ dependence as that found for neurotransmitter release, indicating an association between intracellular free Ca2+ levels and neurotransmitter secretion. The selective BK1-receptor antagonist des-Arg9,[Leu8]BK (where BK is bradykinin) did not significantly affect the stimulation of intracellular free Ca2+ or neurotransmitter release. In contrast, these effects of bradykinin were effectively blocked by the selective BK2-receptor antagonist [Thi5,8,D-Phe7]BK, and mimicked by the BK2 partial agonist [D-Phe7]BK in a concentration-dependent manner. The stimulation of intracellular free Ca2+ and neurotransmitter release induced by bradykinin was shown not to involve voltage-sensitive Ca2+ channels, since calcium antagonists had no effect on either response at concentrations which effectively inhibit depolarization-induced responses. These results indicate that bradykinin, acting through the interaction with the BK2 receptor, stimulates an increase in intracellular free Ca2+ leading to neurotransmitter secretion. Furthermore, bradykinin-induced responses involve the release of intracellular Ca2+ and the influx of extracellular Ca2+ that is not associated with the activation of voltage-sensitive Ca2+ channels. 相似文献
16.
Effect of bradykinin on membrane properties of guinea pig bronchial parasympathetic ganglion neurons
Kajekar R Myers AC 《American journal of physiology. Lung cellular and molecular physiology》2000,278(3):L485-L491
The effect of bradykinin on membrane properties of parasympathetic ganglion neurons in isolated guinea pig bronchial tissue was studied using intracellular recording techniques. Bradykinin (1-100 nM) caused a reversible membrane potential depolarization of ganglion neurons that was not associated with a change in input resistance. The selective bradykinin B(2) receptor antagonist HOE-140 inhibited bradykinin-induced membrane depolarizations. Furthermore, the cyclooxygenase inhibitor indomethacin attenuated bradykinin-induced membrane depolarizations to a similar magnitude ( approximately 70%) as HOE-140. However, neurokinin-1 and -3 receptor antagonists did not have similar inhibitory effects. The ability of bradykinin to directly alter active properties of parasympathetic ganglion neurons was also examined. Bradykinin (100 nM) significantly reduced the duration of the afterhyperpolarization (AHP) that followed four consecutive action potentials. The inhibitory effect of bradykinin on the AHP response was reversed by HOE-140 but not by indomethacin. These results indicate that bradykinin can stimulate airway parasympathetic ganglion neurons independent of sensory nerve activation and provide an alternative mechanism for regulating airway parasympathetic tone. 相似文献
17.
Shigematsu S Ishida S Gute DC Korthuis RJ 《American journal of physiology. Heart and circulatory physiology》2002,283(6):H2676-H2686
Intravital microscopic techniques were used to examine the mechanisms underlying bradykinin-induced leukocyte/endothelial cell adhesive interactions (LECA) and venular protein leakage (VPL) in single postcapillary venules of the rat mesentery. The effects of bradykinin superfusion to increase LECA and VPL were prevented by coincident topical application of either a bradykinin-B(2) receptor antagonist, a cell-permeant superoxide dismutase (SOD) mimetic or antioxidant, or inhibitors of cytochrome P-450 epoxygenase (CYPE) or protein kinase C (PKC) but not by concomitant treatment with either SOD, a mast cell stabilizer, or inhibitors of nitric oxide synthase, cyclooxygenase, xanthine oxidase, NADPH oxidase, or platelet-activating factor. Immunoneutralizing P-selectin or intercellular adhesion molecule-1 (ICAM-1) completely prevented bradykinin-induced leukocyte adhesion and emigration but did not affect VPL. On the other hand, stabilization of F-actin with phalloidin prevented bradykinin-induced leukocyte emigration and VPL but did not alter leukocyte adhesion. These data indicate that bradykinin induces LECA in rat mesenteric venules via a B(2)-receptor-initiated, CYPE-, oxidant- and PKC-mediated, P-selectin- and ICAM-1-dependent mechanism. Bradykinin also produced VPL, an effect that was initiated by stimulation of B(2) receptors and involved CYPE and PKC activation, oxidant generation, and cytoskeletal reorganization but was independent of leukocyte adherence and emigration. 相似文献
18.
We have recently shown that not only bradykinin, but also all components for the production of bradykinin, can be detected within the follicle of porcine ovaries. To elucidate the relevance of the intrafollicular bradykinin-producing system to its physiological role, we investigated the distribution of bradykinin receptor (B(2)R) mRNA and the protein in porcine ovaries. A cDNA encoding porcine B(2)R was first cloned from a porcine uterus cDNA library. The receptor mRNA was scarcely detected in the ovary by Northern blot analysis. Polymerase chain reaction analysis with total RNAs isolated from the ovary and from granulosa cells of small and large follicles demonstrated the ovarian expression of B(2)R mRNA. The B(2)R protein was detected by Western blot analysis in extracts of isolated granulosa cells. In situ hybridization of B(2)R mRNA and immunohistochemical analysis of the protein revealed that the receptor is expressed in the theca and granulosa cells of all growing follicles. The effect of bradykinin on the expression of some matrix metalloproteinase (MMP) genes was examined using isolated granulosa cells. Bradykinin treatment induced MMP-3 and MMP-20 gene expression to an extreme degree. The expression of MT1-MMP was also affected by bradykinin treatment. These results suggest that MMPs play a role in follicle rupture during ovulation. The present study provides new information regarding the mechanisms of bradykinin-induced ovulation in porcine ovaries. 相似文献
19.
Nakamura K Zuppini A Arnaudeau S Lynch J Ahsan I Krause R Papp S De Smedt H Parys JB Muller-Esterl W Lew DP Krause KH Demaurex N Opas M Michalak M 《The Journal of cell biology》2001,154(5):961-972
Calreticulin is a Ca2+-binding chaperone in the endoplasmic reticulum (ER), and calreticulin gene knockout is embryonic lethal. Here, we used calreticulin-deficient mouse embryonic fibroblasts to examine the function of calreticulin as a regulator of Ca2+ homeostasis. In cells without calreticulin, the ER has a lower capacity for Ca2+ storage, although the free ER luminal Ca2+ concentration is unchanged. Calreticulin-deficient cells show inhibited Ca2+ release in response to bradykinin, yet they release Ca2+ upon direct activation with the inositol 1,4,5-trisphosphate (InsP3). These cells fail to produce a measurable level of InsP3 upon stimulation with bradykinin, likely because the binding of bradykinin to its cell surface receptor is impaired. Bradykinin binding and bradykinin-induced Ca2+ release are both restored by expression of full-length calreticulin and the N + P domain of the protein. Expression of the P + C domain of calreticulin does not affect bradykinin-induced Ca2+ release but restores the ER Ca2+ storage capacity. Our results indicate that calreticulin may play a role in folding of the bradykinin receptor, which affects its ability to initiate InsP3-dependent Ca2+ release in calreticulin-deficient cells. We concluded that the C domain of calreticulin plays a role in Ca2+ storage and that the N domain may participate in its chaperone functions. 相似文献
20.
Bradykinin is a potent mediator of inflammation that has been shown to participate in allergic airway inflammation. The biologic effects of bradykinin are mediated by binding and activation of its cognate receptor, the B(2) receptor (B(2)R). In the lung fibroblast cell line IMR-90, binding of bradykinin to B(2)R triggers down-regulation of receptor surface expression, suggesting that bradykinin-induced inflammation is transient and self-limited. Notably, subjects with chronic airway inflammation continue to respond to BK following a first challenge. B(2)Rs are expressed on many different lung cell types, including airway epithelial cells. We therefore compared IMR-90 cells with the human lung epithelial cell line BEAS2B and found that B(2)R expression in the two cell types is differently regulated by BK. Whereas BK induces down-regulation of B(2)R in IMR-90 cells, the same treatment leads to up-regulation of the receptor in BEAS2B cells. These results provide a possible explanation for the potency of bradykinin in inducing ongoing airway inflammation. 相似文献